Survey assessment of continuation of and satisfaction with pharmacological treatment for urinary incontinence

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Ulka B CampbellRich Barron

Abstract

To evaluate treatment satisfaction and compliance with pharmacologic therapy in urinary incontinence patients. An online survey was returned by 1447 individuals from a nationwide panel of adults who had previously reported treatment for incontinence symptoms and agreed to participate in survey research. Data on demographics, incontinence severity, treatment compliance, and satisfaction were obtained. Logistic regression was used to estimate crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for characteristics associated with pharmacologic treatment dissatisfaction and discontinuation. The sample was predominantly female (87%) and white (93%) with a mean age of 56 years. On average, patients urinated 10 times/day and experienced 16 wetting accidents in the week preceding survey. Overall, 25% reported being somewhat or very dissatisfied with treatment. Those who reported a severe effect of incontinence on their lives were most likely to be dissatisfied (OR = 2.82, 95% CI = 1.89-4.23). Discontinuation of drug treatment was reported by 45% of study subjects, with major reasons being poor efficacy (in 41.3% of discontinuations), side effects (22.4%), and cost (18.7%). Predictors for discontinuation included you...Continue Reading

References

Mar 24, 1998·Urology·T H Wagner, T W Hu
Apr 29, 1998·Journal of the American Geriatrics Society·R O RobertsM M Lieber
Dec 22, 1999·American Journal of Obstetrics and Gynecology·A G ViscoR C Bump
Apr 11, 2001·International Urogynecology Journal and Pelvic Floor Dysfunction·C F Jabs, S L Stanton
May 26, 2001·World Journal of Urology·R A AppellA Wein
Mar 5, 2003·BJU International·A MattiassonUNKNOWN Tolterodine Scandinavian Study Group
Jun 18, 2003·Urology·Teh-Wei HuTimothy L Hunt
Jun 18, 2003·World Journal of Urology·W F StewartA J Wein
Aug 11, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yanni F YuJeonghoon Ahn
Oct 4, 2005·Current Medical Research and Opinion·Scott MacDiarmid, Matt Rosenberg

❮ Previous
Next ❯

Citations

Nov 4, 2010·Archives of Gynecology and Obstetrics·Katharina JundtUrsula Peschers
Oct 5, 2013·Clinical Therapeutics·Michael B ChancellorDenise Globe
Aug 16, 2016·International Journal of Urology : Official Journal of the Japanese Urological Association·Yoshinori TanakaNaoya Masumori
Oct 6, 2016·International Neurourology Journal·Kirill Vladimirovich KosilovAnkudinov Ivan Ivanovich
Oct 7, 2016·Health Psychology Review·Benjamin Margolin RottmanWalid F Gellad
Feb 1, 2018·Therapeutic Advances in Urology·Kirill Vladimirovich KosilovAlexandra Prokofyeva
Sep 4, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Peter K SandRodney A Appell
Aug 13, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Michael G Oefelein
Feb 27, 2018·Paediatrics & Child Health·Alexandra FortinStéphane Bolduc
Mar 7, 2017·Investigative and Clinical Urology·Kirill Vladimirovich KosilovAlexandra Lobodenko
Feb 4, 2010·Acta Obstetricia Et Gynecologica Scandinavica·Steinar Hunskaar, Lina Kristin Welle-Nilsen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.